WHO Declares Global Health Emergency: The 2026 Bundibugyo Ebola Outbreak Raising Worldwide Alarm!

 

Bundibugyo Virus Disease Outbreak in the Democratic Republic of the Congo and Uganda in 2026: Implications for Global Health Emergencies and a One Health Perspective.

 

Abstract

 

On 17 May 2026, the World Health Organization (WHO) declared the outbreak of Bundibugyo virus disease (BVD) in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC). BVD is a form of Ebola disease caused by Bundibugyo virus, a member of the genus Ebolavirus. Unlike Zaire Ebola virus disease, no licensed vaccine or specific antiviral treatment is currently available for BVD. The PHEIC declaration was issued due to cross-border transmission, deaths among community members and healthcare workers, the potential for undetected transmission, and limitations in healthcare systems within affected areas. This article discusses the epidemiological characteristics of the outbreak, the rationale behind the PHEIC declaration, challenges in outbreak control, implications for global health security, and its relevance to Indonesia in the context of zoonotic disease preparedness and the One Health approach. Strengthening surveillance, early detection, infection prevention and control, risk communication, and multisectoral coordination are critical factors in preventing further escalation of the outbreak into a broader international public health emergency.

Keywords: Ebola, Bundibugyo virus disease, PHEIC, zoonosis, One Health, WHO, surveillance

 

Introduction

 

Ebola disease is one of the most significant zoonotic diseases with a high case fatality rate and remains a major concern for the international community. The disease is caused by viruses belonging to the genus Ebolavirus, which includes several species such as Zaire ebolavirus, Sudan ebolavirus, and Bundibugyo ebolavirus. Although Bundibugyo virus is reported less frequently than Zaire Ebola virus, it remains capable of causing severe outbreaks of viral hemorrhagic fever.

 

On 17 May 2026, the World Health Organization officially declared the outbreak of Bundibugyo virus disease (BVD) in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern (PHEIC). This designation indicates that the event is considered extraordinary, poses a risk of international spread, and requires a coordinated international response.

 

As of 16 May 2026, the Democratic Republic of the Congo had reported eight laboratory-confirmed cases, 246 suspected cases, and 80 suspected deaths in Ituri Province. Meanwhile, Uganda reported two laboratory-confirmed cases in Kampala among travelers arriving from the DRC, including one fatality. Although the number of confirmed cases remained relatively limited, WHO assessed that there was a substantial risk of wider transmission due to community deaths, infections among healthcare workers, cross-border population movement, and the possibility of transmission within healthcare facilities.

 

This outbreak serves as another reminder that zoonotic diseases can rapidly evolve into international public health emergencies when early detection, response capacity, risk communication, and multisectoral coordination are insufficient. Consequently, the One Health approach plays a crucial role in outbreak prevention and control.

 

Bundibugyo Virus Disease as a Form of Ebola Disease

 

Bundibugyo virus disease is caused by Bundibugyo ebolavirus, one of the Ebola virus species first identified in Uganda in 2007. The disease can present with symptoms including high fever, severe weakness, muscle pain, vomiting, diarrhea, and hemorrhagic manifestations in severe cases.

 

Transmission occurs through direct contact with the blood, bodily fluids, organs, or contaminated surfaces associated with infected individuals or deceased patients. Healthcare workers are particularly vulnerable when infection prevention and control measures are not rigorously implemented.

 

Unlike Zaire Ebola virus disease, for which licensed vaccines are available, no approved vaccine or specific treatment currently exists for Bundibugyo virus disease. Consequently, outbreak control relies heavily on:

1. Early case detection;
2. Patient isolation;
3. Supportive clinical care;
4. Contact tracing;
5. Infection prevention and control (IPC);
6. Safe and dignified burial practices;
7. Risk communication and community engagement.

The absence of vaccines and specific therapeutics makes effective public health interventions the primary means of reducing transmission and mortality.

 

Reasons for the WHO PHEIC Declaration

The WHO decision to declare a PHEIC was based on several epidemiological and operational factors indicating a high risk of further spread.

 

Cross-Border Transmission

Cases identified in Uganda were linked to travel from the Democratic Republic of the Congo, demonstrating international transmission. High levels of population mobility throughout Central and East Africa increase the risk of disease dissemination to other regions.

 

Deaths in Communities and Among Healthcare Workers

Community deaths suggest the presence of cases that may not have been detected by surveillance systems. In addition, infections among healthcare workers indicate weaknesses in the implementation of IPC measures within healthcare facilities.

 

Uncertainty Regarding the True Scale of the Outbreak

The substantially higher number of suspected cases compared with confirmed cases suggests that diagnostic and reporting capacities may not yet fully reflect the actual epidemiological situation.

 

Security and Access Challenges

Security concerns in affected areas can hinder epidemiological investigations, contact tracing, logistics distribution, and healthcare delivery. Such conditions may significantly delay outbreak containment efforts.

 

Risk of Transmission in Healthcare Facilities

Healthcare facilities may become amplification points for disease transmission when IPC standards are not consistently applied, particularly in the context of highly infectious viral hemorrhagic fevers.

 

Travel and Trade Policies

WHO does not recommend restrictions on international travel or trade in response to the current outbreak. This position is based on scientific evidence indicating that border closures have not been shown to effectively prevent disease spread in a significant manner.

 

Moreover, travel restrictions may encourage movement through unofficial routes that are more difficult to monitor, thereby increasing the risk of disease transmission without adequate public health oversight.

 

Instead, WHO recommends the following measures:

• Strengthening surveillance at points of entry;
• Risk-based screening;
• Enhancing healthcare facility preparedness;
• Educating travelers;
• Rapid reporting through International Health Regulations (IHR) mechanisms.

 

Relevance to Indonesia

For Indonesia, the current risk of imported cases is considered low in the absence of travel history or direct exposure to affected areas. Nevertheless, the PHEIC declaration serves as an important reminder of the need to strengthen national preparedness for emerging infectious diseases and zoonoses.

 

Several key areas require continued attention:

 

Strengthening Event-Based Surveillance

Event-based surveillance is essential for rapidly detecting early warning signals, particularly for unusual cases of viral hemorrhagic fever.

Rapid Risk Assessment

The capacity to conduct rapid risk assessments is critical for determining threat levels and implementing appropriate response measures within a short timeframe.

 

Healthcare Facility Preparedness

Hospitals and healthcare facilities should ensure readiness through effective IPC implementation, adequate personal protective equipment (PPE), healthcare worker training, and triage systems for high-risk infectious diseases.

 

Laboratory and Referral Preparedness

Clear specimen referral pathways and sufficient diagnostic laboratory capacity are essential for ensuring rapid and safe case confirmation.

 

Coordination Through the IHR National Focal Point

Multisectoral coordination and international communication through the IHR framework are crucial for facilitating information exchange and supporting effective public health responses.

 

A One Health Perspective

The Bundibugyo virus disease outbreak once again highlights the importance of the One Health approach in addressing global zoonotic threats. Ebola viruses are known to be associated with interactions among humans, wildlife, and the environment.

Ecosystem changes, increased human mobility, wildlife hunting activities, and weaknesses in healthcare systems can all elevate the risk of zoonotic spillover events. Therefore, disease prevention and control cannot focus solely on the human health sector.

 

The One Health approach emphasizes:

• Multisectoral collaboration;
• Integrated surveillance of humans, animals, and the environment;
• Protection of healthcare workers;
• Effective risk communication;
• Community engagement;
• Strengthening public trust in government response efforts.

Failure in any of these components may significantly increase the likelihood of an outbreak escalating into an international public health emergency.

 

Conclusion

 

The declaration of a Public Health Emergency of International Concern for the Bundibugyo virus disease outbreak in the Democratic Republic of the Congo and Uganda demonstrates that zoonotic diseases remain a major challenge to global health security. Although the number of confirmed cases remains relatively limited, cross-border transmission, deaths among community members and healthcare workers, and uncertainty regarding the true scale of transmission were key factors leading to the declaration.

 

The absence of vaccines and specific therapeutics for Bundibugyo virus disease places greater emphasis on early detection, surveillance, infection prevention and control, contact tracing, risk communication, and community engagement as the primary strategies for outbreak control. For Indonesia, this event provides an important opportunity to strengthen national preparedness for emerging infectious diseases and zoonotic threats through an integrated One Health approach.

 

References

 

1. World Health Organization. Ebola virus disease. Geneva: WHO.
2. World Health Organization. International Health Regulations (2005). Geneva: WHO.
3. Centers for Disease Control and Prevention. Ebola (Ebola Virus Disease). Atlanta: CDC.
4. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849–862.
5. Jacob ST, Crozier I, Fischer WA, et al. Ebola virus disease. Nature Reviews Disease Primers. 2020;6:13.
6. Kuhn JH, Amarasinghe GK, Perry DL. Filoviruses and filoviral diseases. Journal of Infectious Diseases. 2019.
7. One Health High-Level Expert Panel. One Health Joint Plan of Action. Geneva: WHO, FAO, UNEP, WOAH.

 

#Ebola2026

#BundibugyoVirus

#GlobalHealthEmergency

#OneHealth

#WHOAlert